Farhana Ali-Geiger
No Rating Available
(Learn About Our Rating System)

Farhana Ali-Geiger, MD

Languages spoken: Bengali, English

Clinical Locations

Primary Location

Primary Children's Hospital

Pediatric Gastroenterology
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
Get Directions

Dr. Farhana Ali-Geiger (née Ali) received her medical degree from the University of California, San Diego (UCSD) School of Medicine. She completed her pediatric residency at Loma Linda University Children’s Hospital and returned to San Diego for her pediatric gastroenterology fellowship at UCSD/Rady Children’s Hospital. She then pursued additional fellowship training in advanced nutrition with special interest in intestinal rehabilitation at Cincinnati Children’s Hospital Medical Center. She is currently an Assistant Professor of Pediatrics in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Utah. She is board certified in Pediatrics, Pediatric Gastroenterology, and is a diplomate of the National Board of Physician Nutrition Specialists. Her clinical interests primarily entail malnutrition, short bowel syndrome, and pediatric intestinal failure. She has been involved in the development of the intestinal rehabilitation program (IRP) to promote a multidisciplinary approach to the long-term management of children with short bowel syndrome associated intestinal failure, and their complex medical and nutritional needs. She serves as the Medical Director of the IRP clinic.

Specialties

Board Certification

American Board of Pediatrics (Sub: Pediatric Gastroenterology)
American Board of Pediatrics (Pediatrics)
National Board of Physician Nutrition Specialists (NBPNS)

Dr. Farhana Ali-Geiger (née Ali) received her medical degree from the University of California, San Diego (UCSD) School of Medicine. She completed her pediatric residency at Loma Linda University Children’s Hospital and returned to San Diego for her pediatric gastroenterology fellowship at UCSD/Rady Children’s Hospital. She then pursued additional fellowship training in advanced nutrition with special interest in intestinal rehabilitation at Cincinnati Children’s Hospital Medical Center. She is currently an Assistant Professor of Pediatrics in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Utah. She is board certified in Pediatrics, Pediatric Gastroenterology, and is a diplomate of the National Board of Physician Nutrition Specialists. Her clinical interests primarily entail malnutrition, short bowel syndrome, and pediatric intestinal failure. She has been involved in the development of the intestinal rehabilitation program (IRP) to promote a multidisciplinary approach to the long-term management of children with short bowel syndrome associated intestinal failure, and their complex medical and nutritional needs. She serves as the Medical Director of the IRP clinic.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Gastroenterology, Hepatology, & Nutrition
Board Certification
American Board of Pediatrics (Sub: Pediatric Gastroenterology)
American Board of Pediatrics (Pediatrics)
National Board of Physician Nutrition Specialists (NBPNS)

Education history

Undergraduate Integrative Biology - University of California, Berkeley B.A.
Professional Medical Medicine - University of California, San Diego School of Medicine M.D.
Residency Pediatrics - Loma Linda University School of Medicine Resident
Fellowship Pediatric Gastroenterology, Hepatology and Nutrition - University of California, San Diego School of Medicine Clinical Fellow
Fellowship Advanced Nutrition - Cincinnati Children's Hospital Medicine Center Clinical Fellow

Selected Publications

Journal Article

  1. Hajam IA, Ali F, Young J, Garcia MA, Cannavino C, Ramchandar N, Liu G (2021). Anti-Inflammatory Properties of Plasma from Children with Short Bowel Syndrome. Pathogens (Basel, Switzerland), 10(8),
  2. Marotz C, Belda-Ferre P, Ali F, Das P, Huang S, Cantrell K, Jiang L, Martino C, Diner RE, Rahman G, McDonald D, Armstrong G, Kodera S, Donato S, Ecklu-Mensah G, Gottel N, Salas Garcia MC, Chiang LY, Salido RA, Shaffer JP, Bryant MK, Sanders K, Humphrey G, Ackermann G, Haiminen N, Beck KL, Kim HC, Carrieri AP, Parida L, Vázquez-Baeza Y, Torriani FJ, Knight R, Gilbert J, Sweeney DA, Allard S (2021). SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment. Microbiome, 9(1), 132.
  3. Huey SL, Jiang L, Fedarko MW, McDonald D, Martino C, Ali F, Russell DG, Udipi SA, Thorat A, Thakker V, Ghugre P, Potdar RD, Chopra H, Rajagopalan K, Haas JD, Finkelstein JL, Knight R, Mehta (2020). Nutrition and the Gut Microbiota in 10- to 18-Month-Old Children Living in Urban Slums of Mumbai, India. mSphere, 5(5),
  4. Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N, Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH, ACTT-2 Study Group Members (2021). Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. The New England journal of medicine, 384(9), 795-807.
  5. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC, ACTT-1 Study Group Members (2020). Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine, 383(19), 1813-1826.
  6. Ali F, Kocoshis S (2022). 50 Years Ago in The Journal of Pediatrics: Growing and Adapting Despite Intestinal Failure. The Journal of pediatrics, 241, 82.
  7. Ali F, Mouzaki (2021). 50 Years Ago in The Journal of Pediatrics: MCTs: Are They what We want Them to Be?. The Journal of pediatrics, 236, 94.
  8. Martino C, Kellman BP, Sandoval DR, Clausen TM, Cooper R, Benjdia A, Soualmia F, Clark AE, Garretson AF, Marotz CA, Song SJ, Wandro S, Zaramela LS, Salido RA, Zhu Q, Armingol E, Vázquez-Baeza Y, McDonald D, Sorrentino JT, Taylor B, Belda-Ferre P, Das P, Ali F, Liang C, Zhang Y, Schifanella L, Covizzi A, Lai A, Riva A, Basting C, Broedlow CA, Havulinna AS, Jousilahti P, Estaki M, Kosciolek T, Kuplicki R, Victor TA, Paulus MP, Savage KE, Benbow JL, Spielfogel ES, Anderson CAM, Martinez ME, Lacey JV Jr, Huang S, Haiminen N, Parida L, Kim H-C, Gilbert JA, Sweeney DA, Allard SM, Swafford AD, Cheng S, Inouye M, Niiranen T, Jain M, Salomaa V, Zengler K, Klatt NR, Hasty J, Berteau O, Carlin AF, Esko JD, Lewis NE, Knight (2025). SARS-CoV-2 infectivity can be modulated through bacterial grooming of the glycocalyx. mBio, 16(4), e0401524.
  9. Ali F, Cole CR, Hornung L, Mouzaki M, Wasserman H, Kalkwarf H (2023). Age-related trajectory of bone density in children with intestinal failure: A longitudinal retrospective cohort study. JPEN. Journal of parenteral and enteral nutrition, 47(6), 736-745.
  10. Kozman M, Ali F, Keller B, Hershey (2022). Hematemesis From Varices in a 14-year-old Without Hepatobiliary Disease: A "Wandering" Diagnosis. Pediatrics, 149(5),
  11. Minich JJ, Ali F, Marotz C, Belda-Ferre P, Chiang L, Shaffer JP, Carpenter CS, McDonald D, Gilbert J, Allard SM, Allen EE, Knight R, Sweeney DA, Swafford A (2021). Feasibility of using alternative swabs and storage solutions for paired SARS-CoV-2 detection and microbiome analysis in the hospital environment. Microbiome, 9(1), 25.
  12. Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Grou (2024). Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials. EClinicalMedicine, 69, 102472.
  13. Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE, Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Member (2024). SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir. The Journal of infectious diseases, 230(3), 624-634.

Review

  1. Chavira A, Belda-Ferre P, Kosciolek T, Ali F, Dorrestein PC, Knight (2019). The Microbiome and Its Potential for Pharmacology. Handbook of experimental pharmacology, 260, 301-326.
  2. Ali F, Mouzaki (2024). Nutritional deficiencies in children. Current opinion in gastroenterology, 40(2), 106-111.

Book

  1. Ali F, Sivagnanam M, Yu L (2019). GI Fellow Handbook. 17th Edition, 2019-2020.
  2. Ali F, Ermarth A (2023). Pediatric Gastroenterology Handbook. 1st Edition, 2023-2024.

Commentary

  1. Ali F, Sweeney D (2020). Throat-Wash Testing and Coronavirus Disease 2019: Should We Put Our Money Where Our Mouth Is?. Clinical infectious diseases, 71(8), 1982-1983.

Case Report

  1. Ali-Geiger F, Traynor M, Baumann L, Bucher (2025). Case of neonate with total intestinal hirschsprung disease managed with a proximal jejunostomy. Intestinal Failure, 5,

Editorial

  1. Ali F, Sweeney D (2021). No One Likes a Stick up Their Nose: Making the Case for Saliva-based Testing for Coronavirus Disease 2019 (COVID-19). Clinical infectious diseases, 72(9), e357-e358.
  2. Ali F, Sweeney D (2020). In Pursuit of Microbiome-based Therapies for Acute Respiratory Failure. American journal of respiratory and critical care medicine, 202(12), 1616-1618.